Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Mycodern Spolka Akcyjna specializes in medical innovations, particularly in dermatology and fungal infection treatments. The company combines advanced research with state-of-the-art production to create effective healthcare solutions. Its commitment to addressing unmet medical needs has positioned it as a trusted name in the biotechnology industry. Mycodern aims to improve patient outcomes through innovative and accessible treatments for skin-related conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-08 15:20
Share Issue/Capital Change
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Share Issue/Capital Change
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Related Party Transaction
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Prospectus
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Report Publication Announcement
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Related Party Transaction
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB
2023-12-31 20:02
Major Shareholding Notification
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 183.3 KB
2023-12-31 20:02
Major Shareholding Notification
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 181.8 KB
2023-12-31 20:02
Declaration of Voting Results & Voting Rights Announcements
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
Polish 637 bytes
2023-12-29 22:27
Prospectus
MCD - dokument ofertowy (seria E)
Polish 444.1 KB
2023-12-29 22:27
Report Publication Announcement
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 728 bytes
2023-11-29 14:02
Prospectus
MCD - Dokument ofertowy
Polish 400.2 KB
2023-11-29 14:02
Share Issue/Capital Change
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.5 KB
2023-10-23 21:09
Share Issue/Capital Change
Formularz zapisu - seria E
Polish 168.3 KB
2023-10-23 21:09
Prospectus
Dokument Ofertowy - seria E
Polish 353.1 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mycodern Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden
MVIR
Sweden
MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland
MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden
ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.